Link Between Metabolic Syndrome and Ruptured Intracranial Aneurysms

Overview

This study investigates the association between metabolic syndrome (MetS) and the status of ruptured intracranial aneurysms (IAs) in a treated patient cohort. Findings indicate that MetS is more prevalent in patients with ruptured IAs, with specific components such as elevated glucose and reduced HDL cholesterol showing strong associations with rupture status.

Background

Intracranial aneurysm rupture can lead to subarachnoid hemorrhage, significantly impacting patient morbidity and mortality. Identifying risk factors for rupture is critical, as existing models have limitations in predictive accuracy. Metabolic syndrome, characterized by a cluster of metabolic abnormalities, may influence vascular health and could be a relevant factor in assessing rupture risk.

Data Highlights

Key Findings

• MetS was more prevalent in the ruptured group (59.9%) compared to the unruptured group (40.1%).
• Binary MetS was independently associated with ruptured status (adjusted OR 1.83).
• Higher MetS scores correlated with increased risk of rupture.
• Elevated glucose, reduced HDL cholesterol, and elevated blood pressure were the strongest individual predictors of rupture status.
• The component-based model demonstrated moderate discrimination with an AUC of 0.711.

Clinical Implications

Healthcare professionals should consider metabolic syndrome as a potential risk factor for intracranial aneurysm rupture. Monitoring and managing components of MetS, such as glucose levels and lipid profiles, may be beneficial in patients with known aneurysms.

Conclusion

The association between metabolic syndrome and ruptured intracranial aneurysms highlights the need for further research to validate these findings and explore their implications for clinical practice.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage - Professional Heart Daily | American Heart Association
6. International Subarachnoid Aneurysm Trial (ISAT)
7. Metabolic pathway and genetically causal links of 1,400 circulating metabolites
8. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage - Professional Heart Daily | American Heart Association